U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

SRX11208442: 08-P02-postoperative
1 ILLUMINA (NextSeq 500) run: 32,360 spots, 2.5M bases, 966,827b downloads

Design: Cell-free DNA libraries were prepared using the KAPA Hyper Prep Kit (KAPA Biosystems) following the manufacturer's protocol.
Submitted by: 3D Medicines Inc., Shanghai, China
Study: ctDNA and cfDNA in the Perioperative Period to Predict the Recurrence Risk in Early NSCLC
show Abstracthide Abstract
In this study, dynamic changes of ctDNA and cfDNA in the perioperative period of NSCLC were used to explore the possibility of them as biomarkers to indicate the risk of recurrence. And we found that the cfDNA levels are raised by the operation overall, but will be polarized after surgery in 7 days. Patients with perioperative elevated cfDNA may have a higher risk of recurrence. We may have identified a biomarker that is more readily available than ctDNA to predict the risk of NSCLC recurrence after surgery.
Sample: 08-P02-postoperative
SAMN19838054 • SRS9262778 • All experiments • All runs
Organism: Homo sapiens
Library:
Name: 45392P03
Instrument: NextSeq 500
Strategy: Targeted-Capture
Source: GENOMIC
Selection: Hybrid Selection
Layout: PAIRED
Runs: 1 run, 32,360 spots, 2.5M bases, 966,827b
Run# of Spots# of BasesSizePublished
SRR1489310032,3602.5M966,827b2021-06-24

ID:
14950586

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...